The largest database of trusted experimental protocols

24 protocols using luciferin ipa

1

Hepatocyte Viability and CYP3A4 Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hoechst 33342 was purchased from Dojindo Laboratories (Kumamoto, Japan). Normal goat serum, MEM, FBS, Hanks' balanced salt solution (HBSS), and fluorescein diacetate (FD) were purchased from Sigma-Aldrich (St. Louis, MO, USA). DMEM, NEAA, HEPES, antibiotics (penicillin and streptomycin), and LIVE/DEAD Viability/ Cytotoxicity kit were purchased from Life Technologies Corp. (Grand Island, NY, USA). HepaRG TM thaw, seed, general purpose supplement, and HepaRG TM maintenance/ metabolism supplement, basal hepatic cell medium were purchased from Biopredic International (Saint Gregoire, France). P450-Glo CYP3A4 assay kit with Luciferin-IPA were purchased from Promega (Madison, WI, USA). All other reagents not specified above were commercial products of the highest grade.
+ Open protocol
+ Expand
2

CYP3A Activity Assay and Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used a cytochrome P450 3A (CYP3A) Assay and Screening System with Luciferin-IPA (Promega, Madison, MI, USA) to assess CYP3A activity. Samples were treated with a Luciferin-IPA substrate (1:1000) in hepatocyte-maturation medium at 0, 6, and 12 d.a.h. of either 37 °C or 39 °C. We collected the medium after 1 h and added Luciferin Detection Reagent (Promega). After 15 min, the CYP3A activity was measured in each sample with a Synergy HTX multi-mode reader (BioTek Instruments, Inc. Winooski, VT, USA). The activity was normalized based on the total number of cells.
+ Open protocol
+ Expand
3

In Vitro CYP Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitory effects of the test drugs at 10 µM a g a i n s t 8 h u m a n P 4 5 0 s ( C Y P 1 A 1 , C Y P 1 A 2 , CYP1B1, CYP2B6, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) were determined using the P450-Glo CYP1A1 Assay, P450-Glo CYP1A2 Induction/Inhibition assay, P450-Glo CYP1B1 Assay, P450-Glo CYP2B6 Assay, P450-Glo CYP2C9 Assay, P450-Glo CYP2C19 Assay, P450-Glo CYP2D6 Assay, and P450-Glo CYP3A4 Assay with Luciferin-IPA (Promega, Madison, WI, USA), as described previously (Watanabe et al., 2020) , with minor modifications. As enzyme sources, supersomes (Corning, Corning, NY, USA) were used and a brief summary of the reactions is presented in Table S2. The final DMSO concentration in the reaction mixture was < 0.1%, and equivalent amounts of DMSO were added to the vehicle control reactions. Typical P450 inhibitors (Table S2) were used to confirm assay conditions (Watanabe et al., 2020) . The test drugs were used at a constant concentration to compare their inhibitory activity under the same conditions, and 10 µM was selected because it was the highest concentration to be prepared without influence of DMSO on the enzymatic activity.
+ Open protocol
+ Expand
4

Measuring CYP1A2 and CYP3A4 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the measurements of CYP1A2 and CYP3A4 activities, PHHs were grown on 24-well collagen-coated membrane inserts (Costar Transwell-PTFE membrane, 6.5 mm, pore size: 0.4 µm, Corning Incorporated, Kennebunk, ME, US). The hepatocytes were treated with MI-1851 (0, 10, 20, 50 and 100 µM) or the positive control inhibitors (alpha-naphthoflavone, 10 µM, CYP1A2; ketoconazole, 10 µM, CYP3A4). Effects of MI-1851 on CYP1A2 and CYP3A4 activities were determined using P450-Glo CYP450 Assays employing luciferin 1A2 or luciferin IPA (Promega, Madison, Wisconsin, US), according to the manufacturer's instructions.
+ Open protocol
+ Expand
5

CYP3A Enzymatic Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP3A activity was measured with the P450-Glo CYP3A4 assay with Luciferin-IPA (Promega, United Kingdom). A complete medium change to medium containing a 1000-fold dilution of Luciferin-IPA was performed and the plate incubated for 1 h at 37 °C, under flow. Samples from each well were placed in a 96-well assay plate and mixed 1:1 with luciferin detection reagent. The plate was incubated at room temperature for 20 min and luminescence measured relative to a standard curve of beetle luciferin potassium salt (Promega, United Kingdom).
+ Open protocol
+ Expand
6

Quantifying Hepatic Enzyme Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
Albumin was measured using a sandwich-based enzyme linked immunosorbent assay (ELISA, Bethyl Laboratories, Montgomery, TX) with horseradish peroxidase detection and 3,3’5,5’-tetramethylbenzidine substrate (TMB, Rockland Immunochemicals, Boyertown, PA). Urea concentration was measured from collected supernatants using diacetyl monoxime with acid and heat (Stanbio Labs, Boerne, TX).[48 (link)] Absorbance of samples was read on the Synergy H1 multimode plate reader (Biotech, Winooski, VT).
CYP3A4 and CYP2C9 enzyme activities were measured after the incubation of cultures for 1 hour with luciferin-IPA (Promega Life Sciences, Madison, WI) or for 3 hours with luciferin-H (Promega), respectively, followed by the processing of collected supernatants per the manufacturer’s recommendations; luminescence was quantified with the Synergy H1 multimode reader. CYP1A2 and CYP2A6 enzymatic activities were measured by incubating cultures for 1 hour with 50 µM coumarin (Sigma-Aldrich) or for 3 hours with 5 µM 7-ethoxyresorufin (Sigma-Aldrich), respectively. The CYP2A6-generated metabolite, 7-hydroxycoumarin (7-HC), and CYP1A2-generated metabolite, resorufin, in culture supernatants were quantified using fluorescence measurements (excitation/emission 355/460 nm for 7-HC and 550/585 nm for resorufin) on the Synergy H1 multimode reader.
+ Open protocol
+ Expand
7

Quantifying Cell Adhesion and Metabolic Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell adhesion was assessed via double-stranded DNA (dsDNA) content in adherent cells. DNA concentration was measured using an AccuBlue dsDNA quantitation kit (Biotium, Hayward, CA) or a Quant-iT PicoGreen dsDNA assay kit (Molecular Probes, Eugene, OR). Culture supernatants were assayed for albumin levels using a competitive enzyme-linked immunosorbent assay (ELISA, MP Biomedicals, Santa Ana, CA) with horseradish peroxidase detection and 3,3′,5,5′-tetramethylbenzidine (TMB, Rockland Immunochemicals, Boyertown, PA) as the substrate, as previously described.13 Urea concentration in culture supernatants was assessed using a colorimetric endpoint assay utilizing diacetyl monoxime with acid and heat (Stanbio Labs, Boerne, TX).13 CYP3A4 enzyme activity was measured by first incubating the cultures with substrate (luciferin-IPA from Promega Life Sciences, Madison, WI) for 1 hour at 37°C and then detecting the luminescence of the produced metabolite (luciferin) according to the manufacturer’s protocols. CYP2A6 enzyme activity was measured by incubating the cultures with coumarin for 1 hour at 37°C and measuring the fluorescent metabolite, 7-hydroxy-coumarin (Sigma-Aldrich, St. Louis, MO). Absorbance and luminescence for the aforementioned assays were measured using a BioTek (Winooski, VT) Synergy H1 multi-mode plate reader.
+ Open protocol
+ Expand
8

CYP3A4 Activity Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure the CYP3A4 activity, lytic assay was performed by using a P450-Glo CYP3A4 Assay with Luciferin-IPA (Promega) according to the manufacturer’s instructions. The luminescence was read by a Lumat LB 9507 (Berthold Technologies). The CYP3A4 activity was normalized with the protein content per well, which was evaluated with Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
+ Open protocol
+ Expand
9

Measuring CYP3A4 Activity in Spheroids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten spheroids for each condition were cultured in conventional and gas-permeable 24-well plates then washed with PBS. The spheroids were then incubated with 300 µL of growth medium containing 2500-fold diluted Luciferin-IPA (V9001, Promega) in a CO2 incubator (37 °C, 5%) for 6 h. Fifty µL of the incubated medium was then transferred to a 96 well plate (236107, Thermo Fisher Scientific) for luminescence detection, and 50 µL of detection reagent was added to each well followed by incubation in the CO2 incubator for 10 min. Luminescence was detected using a SPARK plate reader (TECAN, Männedorf, Switzerland) and CYP3A4 activity plotted as fold-change compared with the Control condition.
+ Open protocol
+ Expand
10

Thyroid Hormone and CYP3A Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triiodothyronine (T3) and 3-methylcholanthrene (3-MC) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Thyroxine (T4) was purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Dexamethasone (DEX) was purchased from Nacalai tesque (Kyoto, Japan). The P450-Glo TM CYP3A assay with Luciferin-IPA and Luciferin-MultiCYP were purchased from Promega (Fitchburg, WI, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!